- US-listed companies
- Golden Ally Lifetech Group, Inc.
Golden Ally Lifetech Group, Inc.AQPW
Market cap
$2B
P/E ratio
Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
Net Loss | -354,777 | -174,911 | -6,071,587 |
Amortization of ROU asset | - | - | 40,311 |
Payment of lease lability | - | - | 37,628 |
Prepaids | -16,250 | 15,216 | 40,952 |
Accounts payable and accrued liabilities and other | -306 | 28,143 | 23,740 |
Net cash used in Operating Activities | -169,196 | -159,150 | -6,086,115 |
Proceeds from receipt of subscription receivable | - | - | 5 |
Merger consideration paid in cash | - | - | 373,350 |
Proceeds from issuance of common shares | - | 48,731 | - |
Net cash provided by Financing Activities | 186,028 | 48,731 | 5 |
Loan receivable - related party | - | - | 1,000,000 |
Net cash provided by (used) in Investing Activities | - | - | -1,000,000 |
Inflow of Cash | 16,832 | -110,419 | -2,417,405 |
Share cancellation | - | - | 10,875 |